The observation that jSLE patients have higher IFN-α2 levels than JIA patients and HCs, and that those levels are linked to disease activity and flare occurrence, aligns with the established role of this cytokine in the pathogenesis of SLE [6]. Here, IFNA2 is linked to systemic lupus erythematosus.